导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.78% | 55/223 |
| 近一周 | -1.90% | 44/229 |
| 近一月 | -4.10% | 122/229 |
| 近一季 | -5.96% | 128/229 |
| 近半年 | 15.34% | 46/225 |
| 近一年 | 11.89% | 54/218 |
| 近两年 | 39.28% | 68/188 |
| 近三年 | 74.24% | 21/151 |
| 成立以来 | 110.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.22% 211/360 |
25.19% 47/366 |
- - |
- - |
| 2025 | 14.72% 237/358 |
-8.95% 302/340 |
16.16% 80/348 |
8.08% 174/354 |
0.36% 165/358 |
| 2024 | 28.11% 26/329 |
10.41% 35/280 |
8.39% 42/310 |
-1.70% 283/318 |
8.90% 5/329 |
| 2023 | 56.54% 1/275 |
18.96% 16/205 |
21.64% 4/230 |
-2.66% 40/262 |
11.13% 74/276 |
| 2022 | -27.26% 130/201 |
-9.62% 92/153 |
-18.41% 135/164 |
0.98% 22/189 |
-2.31% 176/202 |
| 2021 | 23.05% 32/150 |
1.85% 144/312 |
9.40% 69/328 |
0.84% 60/358 |
9.52% 30/151 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 华夏纳斯达克100ETF(QDII) VS. 建信富时100指数(QDII)人民币A(539003) |